Monica Pizana
Nurse Practitioner · Robstown, TXNPI 1861084220
Payments from drug & device makers
Across 121 payments — averaging $38.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$1K
- Amgen$489
- Bayer$369
- Novo Nordisk$347
- Melinta Therapeutics, LLC$246
- AbbVie$211
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,666100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 25 | $1,111 |
| Amgen(2 entities) | 8 | $489 |
| Bayer | 14 | $369 |
| Novo Nordisk | 6 | $347 |
| Melinta Therapeutics, LLC | 4 | $246 |
| AbbVie | 4 | $211 |
| Medtronic | 3 | $192 |
| Boehringer Ingelheim | 5 | $184 |
| AstraZeneca | 9 | $176 |
| Insmed, Inc. | 12 | $169 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $158 |
| Si-bone, Inc. | 1 | $131 |
| Idorsia Pharmaceuticals US Inc | 1 | $124 |
| Corcept Therapeutics | 1 | $114 |
| Merck | 1 | $105 |
| Inspire Medical Systems, Inc. | 1 | $99 |
| Baxter Healthcare | 3 | $75 |
| GSK | 5 | $73 |
| Pulmonx Corporation | 3 | $65 |
| Intercept Pharmaceuticals, Inc. | 1 | $64 |
| Mylan Specialty L.p. | 3 | $50 |
| Electromed, Inc. | 2 | $36 |
| Lilly USA, LLC | 1 | $22 |
| Philips North America LLC | 1 | $16 |
| BD | 1 | $15 |
| Shield Therapeutics Inc | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza$252
- KRYSTEXXA$238
- Kimyrsa$232
- iFuse Implant$131
- Orbactiv$125
- NURTEC ODT$125
- UBRELVY$124
- Wegovy$124
- QUVIVIQ$124
- COREVALVE EVOLUT R$117
- Korlym$114
- JARDIANCE$109
- VAXNEUVANCE$105
- Repatha$103
- Kerendia$100
How this compares
$4,666 in reported general payments places this provider in the 90th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 79 | $82,208 |
| JardianceEmpagliflozin | 75 | $64,536 |
| TrulicityDulaglutide | 50 | $48,291 |
| OzempicSemaglutide | 39 | $41,682 |
| FarxigaDapagliflozin Propanediol | 53 | $29,825 |
| JanuviaSitagliptin Phosphate | 37 | $20,827 |
| KerendiaFinerenone | 21 | $14,109 |
| EliquisApixaban | 19 | $13,118 |
| Advair HfaFluticasone Propion/Salmeterol | 28 | $10,899 |
| VascepaIcosapent Ethyl | 19 | $8,711 |
| EntrestoSacubitril/Valsartan | 12 | $8,175 |
| MyrbetriqMirabegron | 13 | $5,707 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $3,589 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $2,501 |
| Citalopram HbrCitalopram Hydrobromide | 26 | $1,487 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $22 | $130,500129 claims |
| Boehringer IngelheimJardiance | $184 | $64,53675 claims |
| Novo NordiskOzempic | $347 | $41,68239 claims |
| AstraZenecaFarxiga, Symbicort | $176 | $33,41569 claims |
| MerckJanuvia | $105 | $20,82737 claims |
| BayerKerendia | $369 | $14,10921 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in Robstown
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Kelly BrassilHouston$194K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Monica WhiteLongview$118K
- Onna FeuchterSouthlake$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.